[go: up one dir, main page]

MY126562A - Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation - Google Patents

Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation

Info

Publication number
MY126562A
MY126562A MYPI98005639A MYPI19985639A MY126562A MY 126562 A MY126562 A MY 126562A MY PI98005639 A MYPI98005639 A MY PI98005639A MY PI19985639 A MYPI19985639 A MY PI19985639A MY 126562 A MY126562 A MY 126562A
Authority
MY
Malaysia
Prior art keywords
dalfopristine
quinupristine
preparation
pharmaceutical compositions
compositions based
Prior art date
Application number
MYPI98005639A
Inventor
Conrath Guillaume
Vacus Joel
Paul Barker Nicholas
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MY126562A publication Critical patent/MY126562A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

INJECTABLE COMPOSITIONS COMPRISING A DALFOPRISTINE/ QUINUPRISTINE COMBINATION AND AN ADDITIVE WHICH PREVENTS OR REDUCES VENOUS INTOLERANCE EFFECTS IN THE INJECTION REGION.
MYPI98005639A 1997-12-16 1998-12-14 Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation MY126562A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9715911A FR2772272B1 (en) 1997-12-16 1997-12-16 PHARMACEUTICAL COMPOSITIONS BASED ON DALFOPRISTINE AND QUINUPRISTINE AND THEIR PREPARATION

Publications (1)

Publication Number Publication Date
MY126562A true MY126562A (en) 2006-10-31

Family

ID=9514651

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI98005639A MY126562A (en) 1997-12-16 1998-12-14 Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation

Country Status (20)

Country Link
EP (1) EP1037652B1 (en)
JP (1) JP4326148B2 (en)
AR (1) AR017875A1 (en)
AT (1) ATE226082T1 (en)
AU (1) AU1568999A (en)
CO (1) CO4980850A1 (en)
DE (1) DE69808793T2 (en)
DK (1) DK1037652T3 (en)
DZ (1) DZ2683A1 (en)
ES (1) ES2184343T3 (en)
FR (1) FR2772272B1 (en)
MA (1) MA26584A1 (en)
MY (1) MY126562A (en)
PE (1) PE20000018A1 (en)
PT (1) PT1037652E (en)
SA (1) SA99190968B1 (en)
TN (1) TNSN98224A1 (en)
TW (1) TWI242447B (en)
WO (1) WO1999030728A1 (en)
ZA (1) ZA9811470B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187746B1 (en) * 1997-12-16 2001-02-13 Rhone-Poulenc Rorer S.A. Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
KR20010075327A (en) 1998-09-25 2001-08-09 로크리지 스코트 엠 Methods for administration of antibiotics
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
DE102005014248A1 (en) * 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Pharmaceutical preparation of N- [5- (aminosulfonyl) -4-methyl-1,3-thiazol-2-yl] -N-methyl-2- [4- (2-pyridinyl) phenyl] acetamide
UA121240C2 (en) * 2015-06-17 2020-04-27 Набріва Терапютикс Гмбх Injectable pharmaceutical formulations of lefamulin
DK3106148T3 (en) 2015-06-18 2018-05-07 Mithra Pharmaceuticals S A Orodispersible dosing unit containing an estetrol component
SMT202200102T1 (en) 2015-06-18 2022-05-12 Estetra Srl Orodispersible dosage unit containing an estetrol component
TWI801561B (en) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 Compounds and their uses for alleviating menopause-associated symptoms
JOP20200260A1 (en) 2018-04-19 2019-10-19 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (en) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 Contraceptive compositions with reduced adverse effects

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2755857B1 (en) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa STABILIZED PHARMACEUTICAL COMPOSITIONS BASED ON QUINUPRISTINE AND DALFOPRISTINE AND THEIR PREPARATION

Also Published As

Publication number Publication date
WO1999030728A1 (en) 1999-06-24
MA26584A1 (en) 2004-12-20
EP1037652B1 (en) 2002-10-16
SA99190968B1 (en) 2006-07-30
PT1037652E (en) 2003-03-31
DE69808793T2 (en) 2003-07-24
DE69808793D1 (en) 2002-11-21
DK1037652T3 (en) 2003-02-10
PE20000018A1 (en) 2000-04-14
JP4326148B2 (en) 2009-09-02
AU1568999A (en) 1999-07-05
EP1037652A1 (en) 2000-09-27
TNSN98224A1 (en) 2005-03-15
FR2772272B1 (en) 2000-01-14
AR017875A1 (en) 2001-10-24
FR2772272A1 (en) 1999-06-18
JP2002508330A (en) 2002-03-19
ZA9811470B (en) 1999-06-15
DZ2683A1 (en) 2003-03-29
ES2184343T3 (en) 2003-04-01
TWI242447B (en) 2005-11-01
ATE226082T1 (en) 2002-11-15
CO4980850A1 (en) 2000-11-27

Similar Documents

Publication Publication Date Title
TR200002299T2 (en) Epothilon compositions.
ZA975065B (en) Delivery needle.
MY109310A (en) Antimicrobial method and formulation employing type ii endoglucosidase and antimicrobial agent
HUP0003920A2 (en) An injection syringe
GB2299425A (en) Specified return determinator
IL124676A0 (en) Improved concentrated injection and infusion solutions for intravenous use
GB9610363D0 (en) Fuel additives and compositions
PL346040A1 (en) Needleless injectors
ZA981132B (en) Methods, compositions and articles for reducing or preventing the effects of inflammation.
EP0648511A3 (en) Injection syringe.
EP1235742A4 (en) Volatile feedstock delivery system and fuel processing system incorporating the same
BR9711420A (en) Needle-free injector
MY126562A (en) Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation
EP0647780A3 (en) Fuel injection nozzle.
DE69421784D1 (en) Fuel compositions, and additives therefor
AU5763598A (en) Injection device
ITMI931007V0 (en) ONE PIN FOR FURNITURE
GB2321500B (en) Fuel injection
GB9725802D0 (en) Fuel injection
GB2295423B (en) Fuel injection pumps
ZA972179B (en) Fuel compositions.
UA48245C2 (en) SUBSTITUTED-2-AMINO-1,2,3,4-TETRAHYDRODIBENZOFURANS AND 2-AMINOCYCLOHEPTA[b]BENZOFURANS USEFUL AS 5-HT1F AGONISTS IN MAMMALS, PHARMACEUTICAL FORMULATION
DE69515196D1 (en) Compatible fuel additive concentrates
GB2277967B (en) Fuel injection pumps
EP0664386A3 (en) Fuel injection pump and prestroke controller therefor.